英語ページ

Publications 2014

  1. Chiba, S., Tsuchiya, N., Horikawa, Y., Narita, S., Inoue, T., Akihama, S., Saito, M., Numakura, K., Tsuruta, H., Huang, M., Satoh, S., Habuchi, T. (2014) Functional mononucleotide repeat polymorphism in the promoter region of HGF is associated with risk and malignant aggressiveness of bladder cancer. Int J Oncol. 44(3):678-684.
  2. Hamada, S., Hinotsu, S., Kawai, K., Yamada, S., Narita, S., Kamba, T., Nishiyama, H., Arai, Y., Habuchi, T., Ogawa, O., Kawakami, K. (2014) Antiemetic efficacy and safety of a combination of palonosetron, aprepitant, and dexamethasone in patients with testicular germ cell tumor receiving 5-day cisplatin-based combination chemotherapy. Support Care Cancer. 22(8):2161-2166.
  3. Hatakeyama, S., Amano, M., Tobisawa, Y., Yoneyama, T., Tsuchiya, N., Habuchi, T., Nishimura, S., Ohyama, C. (2014) Serum N-glycan alteration associated with renal cell carcinoma detected by high throughput glycan analysis. J Urol. 191(3):805-813.
  4. Huang, M., Narita, S., Inoue, T., Tsuchiya, N., Satoh, S., Nanjo, H., Sasaki, T., Habuchi, T. (2014) Diet-induced macrophage inhibitory cytokine 1 promotes prostate cancer progression. Endocr Relat Cancer. 16;21(1):39-50.
  5. Ishibashi, Y., Tobisawa, Y., Hatakeyama, S., Ohashi, T., Tanaka, M., Narita, S., Koie, T., Habuchi, T., Nishimura, S., Ohyama, C. Yoneyama, T. (2014) Serum tri- and tetra-antennary N-glycan is a potential predictive biomarker for castration-resistant prostate cancer. Prostate. 74(15):1521-1529.
  6. Kashima, S., Inoue, T., Chiba, M., Komine, N., Ito, R., Numakura, K., Tsuruta, H., Saito, M., Akihama, S., Narita, S., Tsuchiya, N., Satoh, S., Onishi, H., Habuchi, T. (2014) Renal subcapsular fluid collection caused by penetration of a pancreatic pseudocyst. Urology. 84(5):e23-24.
  7. Komine, N., Narita, S., Kigure, T., Tsuruta, H., Numakura, K., Akihama, S., Saito, M., Inoue, T., Tsuchiya, N., Satoh, S., Nanjo, H., Habuchi, T. (2014) Successful local control of recurrent penile cancer treated with a combination of systemic chemotherapy, irradiation, and Mohs' paste: a case report. Case Rep Oncol. 24;7(2):522-527.
  8. Matsuda, T., Kanayama, H., Ono, Y., Kawauchi, A., Mizoguchi, H., Nakagawa, K., Iwamura, M., Shigeta, M., Habuchi, T., Terachi, T. (2014) Reliability of laparoscopic skills assessment on video: 8-year results of the endoscopic surgical skill qualification system in Japan. J Endourol. 28(11):1374-1378.
  9. Mitsuzuka, K., Koie, T., Narita, S., Kaiho, Y., Yoneyama, T., Tsuchiya, N., Kakoi, N., Kawamura, S., Tochigi, T., Ohyama, C., Habuchi, T., Arai, Y. (2014) Are pathological and oncological outcomes of elderly men treated with radical prostatectomy worse than those of younger men? Matched-pair analysis between patients aged <70 and ≥70 years. Jpn J Clin Oncol. 44(6):587-592.
  10. Numakura, K., Satoh, S., Tsuchiya, N., Saito, M., Nara, T., Huang, M., Tsuruta, H., Akihama, S., Inoue, T., Narita, S., Habuchi, T. (2014) De novo renal cell carcinoma in an allograft kidney treated with nephron-sparing surgery: a case report. Prog Transplant. 24(4):328-331.
  11. Numakura, K., Tsuchiya, N., Akihama, S., Inoue, T., Narita, S., Huang, M., Satoh, S., Habuchi, T. (2014) Successful mammalian target of rapamycin inhibitor maintenance therapy following induction chemotherapy with gemcitabine and doxorubicin for metastatic sarcomatoid renal cell carcinoma. Oncol Lett. 8(1):464-466.
  12. Park, J., Habuchi, T., Arai, Y., Ohyama, C., Inoue, T., Hatakeyama, S., Jeon, S. S., Kwon, G. Y., Kwak, C., Moon, K. C., Kim, C. S., Ahn, H. (2014) Reassessment of prognostic heterogeneity of pT3 renal pelvic urothelial carcinoma: analysis in terms of proposed pT3 subclassification systems. J Urol. 192(4):1064-1071.
  13. Satoh, S., Niioka, T., Kagaya, H., Numakura, K., Inoue, T., Saito, M., Komine, N., Narita, S., Tsuchiya, N., Habuchi, T., Miura, M. (2014) Pharmacokinetic and CYP3A5 pharmacogenetic differences between once- and twice-daily tacrolimus from the first dosing day to 1 year after renal transplantation. Pharmacogenomics. 15(11):1495-1506.
  14. Sutoh Yoneyama, M., Hatakeyama, S., Habuchi, T., Inoue, T., Nakamura, T., Funyu, T., Wiche, G., Ohyama, C., Tsuboi, S. (2014) Vimentin intermediate filament and plectin provide a scaffold for invadopodia, facilitating cancer cell invasion and extravasation for metastasis. Eur J Cell Biol. 93(4):157-169.
  15. Tsuchiya, N., Yuasa, T., Maita, S., Narita, S., Inoue, T., Numakura, K., Saito, M., Satoh, S., Yonese, J., Habuchi, T. (2014) Organ-specific and tumor-size-dependent responses to sunitinib in clear cell renal cell carcinoma. BMC Urol. 11 14:26.
  16. Wijkstra, H., Wijdenes, M., Alken, P., Habuchi, T., Skolarikos, A., Yin, C. J., Preminger, G. (2014) Clinical research office of the endourological society: the highest quality in global data collection. J Endourol. 28(9):1030-1032.
  17. Yoneyama, T., Ohyama, C., Hatakeyama, S., Narita, S., Habuchi, T., Koie, T., Mori, K., Hidari, K. I., Yamaguchi, M., Suzuki, T., Tobisawa, Y. (2014) Measurement of aberrant glycosylation of prostate specific antigen can improve specificity in early detection of prostate cancer. Biochem Biophys Res Commun. 448(4):390-396.

メニューを開く